NEW YORK (AP) - Wal-Mart's final shareholder vote for its board of directors showed another year of dissent against key executives and directors, including its CEO Mike Duke, as the company deals with the fallout from overseas bribery allegations.
S&P BOOSTS OUTLOOK FOR US GOV'T'S LONG-TERM DEBT: WASHINGTON (AP) - Standard & Poor's Ratings Services upgraded its outlook Monday for the U.S. government's long-term debt. S&P cited the government's strengthened finances, a recovering U.S. economy and some easing of Washington's political gridlock.
SACRAMENTO (AP) - PG&E and its contractors have agreed to pay $50.5 million to settle Department of Justice allegations that the utility was responsible for two wildfires that scorched 18,000 acres of national forest land in Northern California.
ALBUQUERQUE, N.M. (AP) - Two employees at a Whole Foods Market store in Albuquerque say they were suspended last month after complaining about being told they couldn't speak Spanish to each other while on the job - a claim the company says was a misunderstanding.
WASHINGTON (AP) - Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as much as previously thought.
SAN FRANCISCO (AP) - Two San Francisco federal judges say juries will have to decide whether drivers for Uber and Lyft were independent contractors, or employees of the ride-hailing companies with all of the protections and benefits the state affords regular workers.
SANTA CLARA (AP) - Intel's stock fell Thursday after the giant chipmaker lowered its first-quarter revenue forecast, citing weak demand for business desktop PCs and a strong dollar that affects revenue from overseas sales.
WASHINGTON (AP) - Fake IRS agents have targeted more than 366,000 people with harassing phone calls demanding payments and threatening jail in the largest scam of its kind in the history of the agency, a federal investigator said Thursday.
WASHINGTON (AP) - The Food and Drug Administration is keeping a bold-letter warning on Pfizer's anti-smoking drug Chantix about suicidal behavior and other psychiatric side effects, after reviewing company findings suggesting the drug does not increase those problems.